Forestell Ben, Battaglia Frank, Sharif Sameer, Eltorki Mohamed, Samaan M Constantine, Choong Karen, Rochwerg Bram
Department of Medicine, Division of Emergency Medicine, McMaster University, Hamilton, ON, Canada.
Department of Medicine, Division of Critical Care, McMaster University, Hamilton, ON, Canada.
Crit Care Explor. 2023 Feb 17;5(2):e0857. doi: 10.1097/CCE.0000000000000857. eCollection 2023 Feb.
In children with diabetic ketoacidosis (DKA), insulin infusions are the mainstay of treatment; however, optimal dosing remains unclear. Our objective was to compare the efficacy and safety of different insulin infusion doses for the treatment of pediatric DKA.
We searched MEDLINE, EMBASE, PubMed, and Cochrane from inception to April 1, 2022.
We included randomized controlled trials (RCTs) of children with DKA comparing intravenous insulin infusion administered at 0.05 units/kg/hr (low dose) versus 0.1 units/kg/hr (standard dose).
We extracted data independently and in duplicate and pooled using a random effects model. We assessed the overall certainty of evidence for each outcome using the Grading Recommendations Assessment, Development and Evaluation approach.
We included four RCTs ( = 190 participants). In children with DKA, low-dose compared with standard-dose insulin infusion probably has no effect on time to resolution of hyperglycemia (mean difference [MD], 0.22 hr fewer; 95% CI, 1.19 hr fewer to 0.75 hr more; moderate certainty), or time to resolution of acidosis (MD, 0.61 hr more; 95% CI, 1.81 hr fewer to 3.02 hr more; moderate certainty). Low-dose insulin infusion probably decreases the incidence of hypokalemia (relative risk [RR], 0.65; 95% CI, 0.47-0.89; moderate certainty) and hypoglycemia (RR, 0.37; 95% CI, 0.15-0.80; moderate certainty), but may have no effect on rate of change of blood glucose (MD, 0.42 mmol/L/hr slower; 95% CI, 1 mmol/L/hr slower to 0.18 mmol/L/hr faster; low certainty).
In children with DKA, the use of low-dose insulin infusion is probably as efficacious as standard-dose insulin, and probably reduces treatment-related adverse events. Imprecision limited the certainty in the outcomes of interest, and the generalizability of the results is limited by all studies being performed in a single country.
在患有糖尿病酮症酸中毒(DKA)的儿童中,胰岛素输注是主要治疗方法;然而,最佳剂量仍不明确。我们的目的是比较不同胰岛素输注剂量治疗儿童DKA的疗效和安全性。
我们检索了从数据库建立至2022年4月1日的MEDLINE、EMBASE、PubMed和Cochrane数据库。
我们纳入了DKA儿童的随机对照试验(RCT),比较以0.05单位/千克/小时(低剂量)与0.1单位/千克/小时(标准剂量)进行静脉胰岛素输注的情况。
我们独立且重复地提取数据,并使用随机效应模型进行汇总。我们使用分级推荐评估、发展和评价方法评估每个结局的总体证据确定性。
我们纳入了四项RCT(n = 190名参与者)。在患有DKA的儿童中,与标准剂量胰岛素输注相比,低剂量胰岛素输注可能对高血糖症缓解时间没有影响(平均差[MD],少0.22小时;95%置信区间,少1.19小时至多0.75小时;中等确定性),或对酸中毒缓解时间没有影响(MD,多0.61小时;95%置信区间,少1.81小时至多3.02小时;中等确定性)。低剂量胰岛素输注可能会降低低钾血症(相对风险[RR],0.65;95%置信区间,0.47 - 0.89;中等确定性)和低血糖症(RR,0.37;95%置信区间,0.15 - 0.80;中等确定性)的发生率,但可能对血糖变化率没有影响(MD,每小时慢0.42毫摩尔/升;95%置信区间,每小时慢1毫摩尔/升至每小时快0.